BioWorld MedTech

Oct. 26, 2011

Accuray gains approval for TomoTherapy DCS component

Accuray (Sunnyvale, California) reported that FDA has granted it 510(k) clearance to market its Dose Control System (DCS), a new feature for Accuray's TomoTherapy device that is said to improve system performance. Read More

French Radiology Congress: The dark horse in PACS, can France take the lead?

Report from Europe: Epigenomics launches Epi proColon 2.0 CE in Europe

Washington roundup: MDT has good efficacy, iffy safety data for Frontiers PMA

Agreements/contracts: Foundation reports collaboration on cancer genomic test with J&JPRD

Financings roundup: EGHC gains new investors to help boost funding drive

Clarification

Court report: DaVita to receive inquiry from HHS on dialysis drug payments

People in the News

Grants roundup: NERI wins $45 million grant for Pediatric Heart Network

Patent roundup: Daxcor reports filing for albumin measurement instrument patent

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...